tiprankstipranks
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Technical Analysis

98 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Xilio Therapeutics’s (XLO) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Xilio Therapeutics is a Buy.
Xilio Therapeutics’s (XLO) 20-Day exponential moving average is 1.14, while Xilio Therapeutics’s (XLO) share price is $1.12, making it a Sell.
Xilio Therapeutics’s (XLO) 50-Day exponential moving average is 1.06, while Xilio Therapeutics’s (XLO) share price is $1.12, making it a Buy.

Xilio Therapeutics (XLO) Pivot Points

May 16, 2024, 02:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.86
0.93
1.03
1.10
1.20
1.28
1.37
Fibonacci
0.93
1.00
1.04
1.10
1.17
1.21
1.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xilio Therapeutics (XLO) Moving Averages

May 16, 2024, 02:23 AM
Period
Simple
Exponential
MA5
1.17Sell
1.15Sell
MA10
1.17Sell
1.16Sell
MA20
1.14Sell
1.14Sell
MA50
1.04Buy
1.06Buy
MA100
0.84Buy
1.08Buy
MA200
1.43Sell
1.56Sell
Xilio Therapeutics’s (XLO) 10-Day exponential moving average is 1.16, while Xilio Therapeutics’s (XLO) share price is $1.12, making it a Sell.
Xilio Therapeutics’s (XLO) 100-Day exponential moving average is 1.08, while Xilio Therapeutics’s (XLO) share price is $1.12, making it a Buy.
Xilio Therapeutics’s (XLO) stock price is $1.12 and Xilio Therapeutics’s (XLO) 50-day simple moving average is 1.04, creating a Buy signal.
Xilio Therapeutics’s (XLO) stock price is $1.12 and Xilio Therapeutics’s (XLO) 100-day simple moving average is 0.84, creating a Buy signal.
Xilio Therapeutics’s (XLO) stock price is $1.12 and Xilio Therapeutics’s (XLO) 200-day simple moving average is 1.43, creating a Sell signal.

Xilio Therapeutics (XLO) Technical Indicators

May 16, 2024, 02:23 AM
Name
Value
Implied Action
RSI (14)
47.79
Neutral
STOCH (9,6)
38.63
Neutral
STOCHRSI (14)
48.51
Neutral
MACD (12,26)
0.03
Buy
ADX (14)
24.26
Neutral
Williams %R
-62.33
Buy
CCI (14)
-37.99
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
49.87
Neutral
ROC
2.83
Buy
Xilio Therapeutics’s (XLO) Relative Strength Index (RSI) is 47.79, creating a Neutral signal.
Xilio Therapeutics’s (XLO) Trend Strength Indicator (ADX) is 24.26, creating a Neutral signal.
Xilio Therapeutics’s (XLO) Commodity Channel Index (CCI) is -37.99, creating a Neutral signal.
Xilio Therapeutics’s (XLO) Price Rate of Change (ROC) is 2.83, creating a Buy signal.

FAQ

Is XLO a Buy, Hold, or Sell?
Based on XLO’s technical indicators, XLO is a Hold.
    What is XLO’s RSI (14)?
    XLO’s RSI (14) is 47.79, which suggests XLO is a Neutral.
      What is XLO’s MACD?
      XLO’s MACD is 0.03, which suggests XLO is a Buy.
        What is XLO’s 5-day moving average?
        XLO’s 5-day moving average is 1.17, which suggests XLO is a Sell.
          What is XLO’s 20-day moving average?
          XLO 20-day moving average is 1.14, which suggests XLO is a Sell.
            What is XLO’s 50-day moving average?
            XLO’s 50-day moving average is 1.04, which suggests XLO is a Buy.
              What is XLO’s 200-day moving average?
              XLO’s 200-day moving average is 1.43, which suggests XLO is a Sell.
                What is XLO’s Williams % R (14)?
                XLO’s Williams % R (14) is -62.33, which suggests XLO is a Buy.
                  What is XLO’s CCI (14)?
                  XLO’s CCI (14) is -37.99, which suggests XLO is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis